Jama Neurology

Error in Byline, Affiliations, and Table 1

2023-04-01
In the Original Investigation titled “Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants,” published online January 3, 2023, there were errors in the byline, Article Information, and Table 1. On the byline, the spelling of Shinichi Wada’s name was fixed, and the middle initial was added to Espen S. Kristoffersen’s name. In the Article Information, the affiliations for Macha and Kallmünzer as well as Salerno and Michel were updated. In the vitamin K antagonists row of Table 1, the values were updated so 689 patients were included in the control column and 0 were included in the patients with recent ingestion of DOACs column. This article was corrected online.

Fonte: Jama Neurology

Trends in Postmortem Neurodegenerative and Cerebrovascular Neuropathologies Over 25 Years

2023-04-01
This cohort study characterizes trends in pathways underlying dementia by examining prevalence of postmortem neuropathologies in birth cohorts across 25 years.

Fonte: Jama Neurology

Changes in the Rate of Leucine-Rich Glioma-Inactivated 1 Seropositivity During the COVID-19 Lockdown

2023-04-01
This case-control study investigates the positivity rates of the most prevalent neuroglial surface antibodies during the COVID-19 pandemic.

Fonte: Jama Neurology

Childhood Educational Quality and Incident Dementia in Black and White Adults

2023-04-01
This cohort study evaluated the association between state-level educational quality during childhood and incident dementia in adults aged 65 years or older.

Fonte: Jama Neurology

Views From Both Sides of the White Coat

2023-04-01
This essay describes the author’s experience as a physician-parent of a chronically ill child.

Fonte: Jama Neurology

Targeting B Cells and Microglia in Multiple Sclerosis With BTK Inhibitors

2023-04-01
This narrative review discusses the use of BTK inhibitors as disease-modifying therapies for multiple sclerosis, outlining their mechanism of action, development, and clinical use and comparing information from clinical trials.

Fonte: Jama Neurology

Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers

2023-04-01
This prognostic study uses data from the Swedish BioFINDER-1 and Wisconsin Registry for Alzheimer Prevention longitudinal cohort studies to evaluate whether combinations of different plasma biomarkers can predict cognitive decline in cognitively unimpaired individuals with β-amyloid positivity.

Fonte: Jama Neurology

Error in Figure

2023-04-01
In the Original Investigation titled “Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease,” published in the November 2021 issue, there were errors in the y-axes of the Figure, E and F. The assays were mislabeled and the amyloid-β types were incorrect for panels E and F. This article was corrected online.

Fonte: Jama Neurology

It’s Time to Rebrand “Mommy Brain”

2023-04-01
This Viewpoint discusses the concept of “mommy brain” and why it needs to change.

Fonte: Jama Neurology

Bibrachial Amyotrophy Due to Spontaneous Spinal Cerebrospinal Fluid Leak

2023-04-01
This case report describes a patient with bibrachial amyotrophy due to spontaneous spinal cerebrospinal fluid leak.

Fonte: Jama Neurology